Tanvex BioPharma, Inc.

Tanvex BioPharma, Inc.

6541.TW
Tanvex BioPharma, Inc.TW flagTaiwan Stock Exchange
40.80
TWD
+0.30
- -
10.81BMarket Cap

Tanvex BioPharma, Inc. (6541.TW) Stock Split History

Learn about Tanvex BioPharma, Inc.'s most recent 333-for-1000 basis stock split on March 02, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Tanvex BioPharma, Inc.'s most recent stock split

Split Date: 2023-03-02
Split Ratio: 333:1000
Price Before Split: $37.14
Price After Split: $12.37

Developer API

Get 6541.TW split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/6541.TW

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 3.00 times fewer shares (a 333:1000 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Tanvex BioPharma, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-03-02333:1000Yes$37.14$12.37

About Tanvex BioPharma, Inc.

Company overview and industry information

Tanvex BioPharma, Inc. (6541.TW) operates in the Biotechnology industry. The recent 333-for-1000 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Tanvex BioPharma, Inc. Summary

Last updated: 7/12/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.